UBS initiated coverage of Emcor (EME) with a Buy rating and $570 price target The company is “poised to outgrow a choppy non-residential construction backdrop,” the analyst tells investors in a research note. The firm believes Emcor’s visibility to continued strong earnings growth in 2026 and 2027 is not sufficiently priced into the shares. UBS sees at least a 7% organic revenue annually through 2027 for the company’s construction businesses, driven by structural investment themes, most notably data centers, semiconductor fabs, and pharmaceutical plants.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EME: